{
    "title": "Regeneron profit beats estimates on Dupixent strength",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11709847/Regeneron-quarterly-profit-plunges-COVID-drug-sales-dry-up.html",
    "date": "2023-02-03",
    "keywords": [
        "drug",
        "eylea",
        "company",
        "dupixent",
        "quarter",
        "profit",
        "fourthquarter",
        "friday",
        "demand",
        "drop",
        "blockbuster",
        "eye",
        "growth",
        "driver",
        "launch",
        "decade",
        "competition",
        "year",
        "loss",
        "causing",
        "degeneration",
        "closing",
        "fund",
        "copay",
        "assistance",
        "month",
        "alternative",
        "companys",
        "partner",
        "sanofi",
        "revenue",
        "booster",
        "regeneron",
        "treatment",
        "asthma",
        "atopic",
        "dermatitis",
        "eczema",
        "share",
        "reporting",
        "aditya",
        "samal",
        "raghav",
        "mahobe",
        "bengaluru",
        "editing",
        "maju",
        "samuel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}